The Short Answer
Mounjaro and Ozempic are different medications, even though they look similar.
In 2026, the most relevant fact: in head-to-head studies, tirzepatide (Mounjaro) tends to produce more weight loss than semaglutide (Ozempic). But both are very effective, and the right choice depends on your situation.
How They Work Differently
This is the part that matters most.
Ozempic / semaglutide activates one receptor in your body: the GLP-1 receptor. GLP-1 is a natural hormone that signals fullness, slows stomach emptying, and stabilizes blood sugar.
Mounjaro / tirzepatide activates two receptors: the GLP-1 receptor AND the GIP receptor. GIP is a second incretin hormone with overlapping but distinct effects on metabolism and appetite.
Activating both signals at once tends to produce stronger appetite suppression and better blood sugar control on average. This is why tirzepatide outperforms semaglutide in head-to-head clinical trials.
Weight Loss Results
This data comes from the largest published trials:
| Medication | Average weight loss | Time | Trial | |---|---:|---:|---| | Mounjaro / tirzepatide (15 mg) | ~20-21% | 72 weeks | SURMOUNT-1 (NEJM 2022) | | Ozempic / semaglutide (2.4 mg) | ~14-15% | 68 weeks | STEP 1 (NEJM 2021) | | Head-to-head | Tirzepatide ~6.5% more loss | 72 weeks | SURMOUNT-5 (NEJM 2025) |
For someone starting at 250 lbs:
These are averages. Some patients lose much more, others less. Real results depend on dose tolerance, lifestyle, and consistency.
Cost in 2026
*Brand-name without insurance:*
With insurance: sometimes $25-100/month, but many plans don't cover weight loss medications.
*Manufacturer programs:*
*Compounded versions through telehealth:*
The compounded route is what makes GLP-1 weight loss accessible for most patients without insurance coverage.
Side Effects Comparison
Both medications share a similar side-effect profile because they overlap on the GLP-1 mechanism. The most common, in the first 4-8 weeks:
| Side Effect | Ozempic / Semaglutide | Mounjaro / Tirzepatide | |---|---:|---:| | Nausea | ~44% | ~25-31% | | Diarrhea | ~30% | ~19-23% | | Vomiting | ~24% | ~8-12% | | Constipation | ~24% | ~11-17% | | Discontinuation due to side effects | ~7% | ~6% |
Tirzepatide tends to cause slightly fewer GI side effects at comparable weight-loss doses. Both can cause significant nausea early on. Most side effects fade within 4-8 weeks.
Both carry the same FDA boxed warning about thyroid C-cell tumors. Both are contraindicated in patients with personal or family history of MTC or MEN2 syndrome.
Dosing and Schedule
Both are once-weekly injections. The titration schedule:
*Ozempic / semaglutide for weight loss:*
*Mounjaro / tirzepatide for weight loss:*
Both follow a slow titration to minimize side effects. Many patients don't need to reach the maximum dose. Some do well long-term at 5-10 mg tirzepatide or 1-1.7 mg semaglutide.
Who Should Choose Which
There's no universal winner. The right choice depends on you.
*Mounjaro / tirzepatide may be better if you:*
*Ozempic / semaglutide may be better if you:*
Switching Between Them
Switching from Ozempic to Mounjaro (or vice versa) is common and physicians do it routinely. The standard approach:
1. Stop the old medication 2. Start the new one at the lowest dose (0.25 mg semaglutide or 2.5 mg tirzepatide) 3. Follow the standard titration schedule, even if you were at a high dose previously 4. Don't try to dose-equivalent jump between them. The pharmacology is different.
Most patients adjust within 2-4 weeks of the switch.
The Honest Bottom Line
Both Mounjaro and Ozempic work. Both are well-studied. Both are real medications, not gimmicks. The question isn't "which is better" but "which is right for you."
Many patients start with semaglutide because it's cheaper and well-tested, then switch to tirzepatide if their results plateau too high. Some go straight to tirzepatide because they want maximum weight loss. Both paths are reasonable.
The most important thing isn't picking the perfect medication. It's working with a real US-licensed physician who reviews your full history, picks the right starting point, and adjusts based on how you respond.
For the deeper comparison between the chemicals themselves, see our tirzepatide vs semaglutide guide.
Frequently Asked Questions
Is Mounjaro stronger than Ozempic?
On average, yes. In head-to-head trials, tirzepatide (Mounjaro) produces about 6.5% more body weight loss than semaglutide (Ozempic) over 72 weeks. But individual responses vary, and tolerability often matters as much as raw efficacy.
Can you switch from Ozempic to Mounjaro?
Yes. The switch is common and physicians do it routinely. You stop Ozempic, then start Mounjaro at the lowest dose (2.5 mg) following the standard titration schedule. Don't try to dose-equivalent jump. The pharmacology is different.
Why is Ozempic cheaper than Mounjaro in compounded form?
Semaglutide has been compounded longer and is widely available from many state-licensed pharmacies. Tirzepatide was added to compounding pipelines later and often comes from fewer suppliers, which keeps prices slightly higher.
Is Mounjaro FDA-approved for weight loss?
Mounjaro itself is FDA-approved for type 2 diabetes only. Tirzepatide for weight loss is FDA-approved under the brand name Zepbound. Mounjaro is often prescribed off-label for weight loss, which is legal and common.
Does Ozempic work for weight loss?
Yes, when prescribed off-label. The active ingredient (semaglutide) is the same as Wegovy, which is FDA-approved for weight loss. Many physicians prescribe Ozempic off-label because it can be more accessible or covered by insurance.